Beta Bionics (BBNX) Operating Leases (2023 - 2026)

Beta Bionics' Operating Leases history runs 4 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Operating Leases fell 6.92% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (down 6.92% YoY), while the FY2025 annual figure was $5.4 million, down 6.3% from the prior year.
• Operating Leases came in at $5.1 million for Q1 2026 at Beta Bionics, down from $5.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $5.7 million in Q4 2024 to a low of $3.0 million in Q4 2023.
• A 4-year average of $5.1 million and a median of $5.4 million in 2025 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases surged 90.93% in 2024 and fell 6.92% in 2026, its largest moves.
• Beta Bionics' Operating Leases stood at $3.0 million in 2023, then soared by 90.93% to $5.7 million in 2024, then slipped by 6.3% to $5.4 million in 2025, then declined by 5.44% to $5.1 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $5.1 million, $5.4 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison